Antibodies which bind to epithelial membrane protein 2 (EMP2)

US9624304B2 · kind B2 · utility

Assignee

• The Regents of the University of California · US

Inventors

• Jonathan Braun · Calabasas, US
• Lynn K. Gordon · Calabasas, US
• Kaori Shimazaki Dadgostar · Los Angeles, US
• Madhuri Wadehra · Manhattan Beach, US
• Kathy A. Kelly · Santa Monica, US
• Anna M. Wu · West Hollywood, US

Key dates

• Filing date: Mar 23, 2015
• Grant date: Apr 18, 2017
• Expiry date: Mar 23, 2035

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07K2319/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present invention provides methods and compositions useful in the treatment or prevention of Chlamydia infections and cancer. The methods and compositions inhibit the entry of Chlamydia into a host cell expressing EMP2 by interfering with the interaction between the Chlamydia and EMP2. The methods and compositions target cancers which express or overexpress EMP2 nucleic acids and polypeptides by targeting EMP2.